Compound offers a potential tool for fighting drug-resistant malaria parasites.

New Global Head of Ophthalmology Research sees the eye as a frontier of biomedical research.

Read how NIBR and Dana-Farber scientists aim to expand immunotherapy options for patients

Ilona, a patient living with polycythemia vera, shares her experiences with this rare blood cancer

Novartis researchers are partnering with advocacy groups to understand the stigma and challenges facing patients with obesity.

Advanced Accelerator Applications is working on marrying targeted drug design with nuclear medicine technology to develop drugs that can recognize and treat diseases.

University students majoring in the life sciences or business often have trouble imagining the direction of their careers.

Myriam Mendila describes how Novartis continued supporting cancer patients and healthcare professionals during the pandemic.

A certain leggy resident of the African grasslands is arousing a lot of interest among evolutionary biologists. They believe that study of giraffes' unique features could lead the way to advances in human health.

Novartis innovation and events such as mHealth Challenge enable patients to access data and personal information about their health via mobile devices.